Sumita Ray - 01 Nov 2023 Form 4 Insider Report for Vaxxinity, Inc.

Reporting relationship: Chief Legal, Comp & Admin Off
Issuer ticker: N/A
Reported as of: 01 Nov 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Apr 2024, 16:15:15 UTC
Prior SEC filing: 11 Oct 2023
Next SEC filing: 13 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Sumita Ray

Key filing fact

Sumita Ray filed Form 4 for Vaxxinity, Inc. on 29 Apr 2024.

Key facts

This page summarizes Sumita Ray's Form 4 filing for Vaxxinity, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 29 Apr 2024, 16:15.

Change

Previous filing in this sequence was filed on 11 Oct 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VAXX transaction Derivative

Employee Stock option (right to buy)

Award

Transaction value: $0
Shares: +425,000
Change %
Price: $0.000000
Shares after: 425,000
Date: 01 Nov 2023
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 425,000
Exercise price: $1.17
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options are subject to a four-year vesting schedule, with 25% vesting one year after the vesting commencement date of October 1, 2023 and the remainder vesting in equal quarterly installments, subject to the Reporting Person's continued service.